XTX Topco’s Citius Pharmaceuticals CTXR Stock Holding History

XTX Topco’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.8K	Buy	59,199 +37,904	+178%	+$25.7K	﹤0.01%	3789
2026 Q1	$19.2K	Sell	21,295 -85,823	-80%	-$69.3K	﹤0.01%	3558
2025 Q4	$83.2K	Buy	107,118 +91,196	+573%	+$114K	﹤0.01%	2685
2025 Q3	$19.7K	Sell	15,922 -4,224	-21%	-$5.89K	﹤0.01%	2334
2025 Q2	$32K	Buy	+20,146	New	+$18.5K	﹤0.01%	2094
2024 Q4	–	Sell	-3,730	Closed	-$46.7K	–	2397
2024 Q3	$46.7K	Buy	+3,730	New	+$62.8K	﹤0.01%	1702
2024 Q2	–	Sell	-3,104	Closed	-$69.6K	–	1975
2024 Q1	$69.6K	Buy	3,104 +2,596	+511%	+$47.4K	0.01%	1416
2023 Q4	$9.62K	Sell	508 -655	-56%	-$12.4K	﹤0.01%	1432
2023 Q3	$19.9K	Buy	+1,163	New	+$27.6K	﹤0.01%	1375

Other funds holding CTXR

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AAG

Asset Advisory Group Kinnelon, New Jersey $229M AUM

BostonPremier Wealth Hanover, Massachusetts $235M AUM 31.01% 1-Year Est. Return

XTX Topco's CTXR Position: Q2 2026 in Review

XTX Topco increased its Citius Pharmaceuticals (CTXR) stake by 178% in Q2 2026, buying an estimated $25.7K and bringing the position to 59,199 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3789.

XTX Topco first reported a position in CTXR in Q3 2023 and has held it in 9 quarters since. The position peaked at $83.2K in Q4 2025. 42 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

XTX Topco held 59,199 shares of Citius Pharmaceuticals worth $35.8K as of Q2 2026.
XTX Topco bought 37,904 Citius Pharmaceuticals shares in Q2 2026, an estimated $25.7K.
Citius Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3789 holding.
XTX Topco first reported a position in Citius Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
XTX Topco's Citius Pharmaceuticals position peaked at $83.2K in Q4 2025.
42 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.